Study: The Number of New Dermatology Drugs Approved by the FDA Is on the Rise
The Dermatology Digest
DECEMBER 20, 2023
Nearly half of these drugs were considered first in class or first in indication, and several were deemed clinically useful or to have high added therapeutic benefit by four health technology assessment organizations (HTAs) in Germany, Canada, or France. Benefit ratings by at least one of the four organizations were available for 38 drugs.
Let's personalize your content